By Dave Simpson ( March 26, 2019, 11:03 PM EDT) -- Proposed consumer classes have reached a $65.8 million deal in a suit claiming Mylan and Ranbaxy participated in pay-for-delay deals with Cephalon to prevent the sale of generic versions of the narcolepsy drug Provigil, they told a Pennsylvania federal court Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.